Loading...
First Round of Abstract Submission Ends: Nov 30, 2026
Extended Early Bird Ends: Apr 28, 2026

Topics

The Organizing Committee welcome abstract submissions on the following topics. Topics of interest for submission include, but are not limited to:

  • Drug Discovery & Development
  • Clinical Pharmacology & Therapeutics
  • Pharmacokinetics and Pharmacodynamics
  • Precision & Personalized Medicine
  • Pharmacogenomics in Practice
  • Molecular & Cellular Pharmacology
  • Receptor Signaling & Drug Targets
  • Cardiovascular Pharmacology
  • Neuropharmacology & CNS Drugs
  • Cancer Pharmacology & Chemotherapy
  • Immunotoxicology and Immunopharmacology
  • Metabolic & Endocrine Pharmacology
  • Nanotechnology in Drug Delivery
  • Biopharmaceuticals & Biosimilars
  • AI & Computational Drug Design
  • Drug Safety & Adverse Reactions
  • Principles of Toxicology
  • Mechanisms of Toxicity
  • Toxicokinetics & Dose–Response
  • Organ-Specific Toxicities
  • Neurotoxicity & Behavioral Toxicology
  • Reproductive & Developmental Toxicology
  • Environmental & Occupational Toxicology
  • Heavy Metals & Chemical Toxicity
  • Regulatory & Safety Toxicology
  • Risk Assessment & Management
  • Toxicovigilance & Drug-Induced Toxicity
  • Nanotoxicology
  • Alternative Methods in Toxicology
  • Endocrine Disruptors & Emerging Risks
  • Ethics in Pharmacology & Toxicology
  • Public Health & Toxic Exposure
  • Pharmacovigilance & Post-Marketing Safety
  • Translational Pharmacology & Toxicology
  • Molecular and Cellular Toxicology
  • Cardiovascular, Respiratory, and Endocrine Toxicology